These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8894558)

  • 21. Maintenance use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk.
    Ma Y; Brusselaers N
    Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):147-152. PubMed ID: 29259292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NSAIDs, Barrett's oesophagus and adenocarcinoma prevention.
    Vainio H; Morgan G
    Eur J Cancer Prev; 1997 Apr; 6(2):200. PubMed ID: 9237071
    [No Abstract]   [Full Text] [Related]  

  • 23. Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants?
    Pandeya N; Webb PM; Sadeghi S; Green AC; Whiteman DC;
    Gut; 2010 Jan; 59(1):31-8. PubMed ID: 19875392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of aspirin and non-aspirin NSAIDs in preventing melanoma.
    Ally MS; Swetter SM; Tang JY
    Future Oncol; 2013 Nov; 9(11):1671-4. PubMed ID: 23731359
    [No Abstract]   [Full Text] [Related]  

  • 25. Aspirin, NSAIDs, and risk reduction of colorectal cancer. The problem is translation.
    Waterhouse DM; Brenner D
    Arch Intern Med; 1994 Feb; 154(4):366-8. PubMed ID: 8117168
    [No Abstract]   [Full Text] [Related]  

  • 26. Beneficial effects of NSAIDs in the gastrointestinal tract.
    Morgan G
    Eur J Gastroenterol Hepatol; 1999 Apr; 11(4):393-400. PubMed ID: 10321755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aspirin and non-steroidal anti-inflammatory drugs use reduce gastric cancer risk: A dose-response meta-analysis.
    Huang XZ; Chen Y; Wu J; Zhang X; Wu CC; Zhang CY; Sun SS; Chen WJ
    Oncotarget; 2017 Jan; 8(3):4781-4795. PubMed ID: 27902474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-aspirin non-steroidal anti-inflammatory drugs for the primary chemoprevention of non-gastrointestinal cancer: summary of evidence.
    Silva MT; Galvao TF; Zimmerman IR; Pereira MG; Lopes LC
    Curr Pharm Des; 2012; 18(26):4047-70. PubMed ID: 22632754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspirin and NSAIDs for the prevention of colorectal cancer.
    Baron JA
    Recent Results Cancer Res; 2009; 181():223-9. PubMed ID: 19213572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of aspirin and nonsteroidal anti-inflammatory drug use after diagnosis on survival of oesophageal cancer patients.
    van Staalduinen J; Frouws M; Reimers M; Bastiaannet E; van Herk-Sukel MP; Lemmens V; de Steur WO; Hartgrink HH; van de Velde CJ; Liefers GJ
    Br J Cancer; 2016 Apr; 114(9):1053-9. PubMed ID: 27115570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aspirin and nonsteroidal anti-inflammatory drugs can prevent cutaneous squamous cell carcinoma: a systematic review and meta-analysis.
    Muranushi C; Olsen CM; Pandeya N; Green AC
    J Invest Dermatol; 2015 Apr; 135(4):975-983. PubMed ID: 25521453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspirin, NSAIDS, and colon cancer prevention: mechanisms?
    Gupta RA; DuBois RN
    Gastroenterology; 1998 May; 114(5):1095-8. PubMed ID: 9606094
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of aspirin and NSAIDs on colorectal adenomas. Protective effect may be spurious.
    Lo SV; Perry HU; Lyons R
    BMJ; 1993 Sep; 307(6906):734. PubMed ID: 8401104
    [No Abstract]   [Full Text] [Related]  

  • 34. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence.
    Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; Comber H; McGuigan J; Reynolds JV; Murray LJ
    Cancer Res; 2006 May; 66(9):4975-82. PubMed ID: 16651456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study.
    Masclee GM; Coloma PM; Spaander MC; Kuipers EJ; Sturkenboom MC
    BMJ Open; 2015 Jan; 5(1):e006640. PubMed ID: 25633286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspirin and NSAIDs for breast cancer chemoprevention.
    Yiannakopoulou ECh
    Eur J Cancer Prev; 2015 Sep; 24(5):416-21. PubMed ID: 25380191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis.
    González-Pérez A; García Rodríguez LA; López-Ridaura R
    BMC Cancer; 2003 Oct; 3():28. PubMed ID: 14588079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Daily use of non-steroidal anti-inflammatory drugs is less frequent in patients with Barrett's oesophagus who develop an oesophageal adenocarcinoma.
    Tsibouris P; Hendrickse MT; Isaacs PE
    Aliment Pharmacol Ther; 2004 Sep; 20(6):645-55. PubMed ID: 15352913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma.
    Cerhan JR; Anderson KE; Janney CA; Vachon CM; Witzig TE; Habermann TM
    Int J Cancer; 2003 Sep; 106(5):784-8. PubMed ID: 12866040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of non-steroidal anti-inflammatory drugs, aspirin and the risk of depression: The "Seguimiento Universidad de Navarra (SUN)" cohort.
    Molero P; Ruiz-Estigarribia L; Lahortiga-Ramos F; Sánchez-Villegas A; Bes-Rastrollo M; Escobar-González M; Martínez-González MÁ; Fernández-Montero A
    J Affect Disord; 2019 Mar; 247():161-167. PubMed ID: 30669075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.